Quebec’s IVF restrictions: Economics or ethics?
By MARINA ADSHADE,
The Globe and Mail
| 12. 12. 2014
Last week, Quebec Health Minister Gaétan Barrette tabled a bill
that, if passed, will prohibit women over the age of 42 from having
access to in vitro fertilization (IVF). While the purpose of the bill,
on the surface at least, is to lessen financial strain on the health
care system, this particular section of the bill will achieve a
different outcome; it will reduce the number of births to Quebec women
who rely on the use of donated eggs to conceive.
More Related to this Story
Quebec started providing medicare for
assistive reproductive technologies (ART) in 2010 in the hope of
achieving three objectives: reduce health care costs resulting from
multiple births; enable infertile couples to have children; and increase
the number of births in the province by between 1,000 and 1,500 per
year.
Despite claims that the program
has been widely abused, the number of births to Quebec woman has only
fallen since...
Related Articles
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...
Following a long-standing CGS tradition, we present a selection of our favorite Biopolitical Times posts of the past year.
In 2025, we published up to four posts every month, written by 12 authors (staff, consultants and allies), some in collaboration and one simply credited to CGS.
These titles are presented in chronological order, except for three In Memoriam notices, which follow. Many more posts that are worth your time can be found in the archive. Scroll down and “VIEW...
By Jonathan Matthews, GMWatch | 12.11.2025
In our first article in this series, we investigated the dark PR tactics that have accompanied Colossal Bioscience’s de-extinction disinformation campaign, in which transgenic cloned grey wolves have been showcased to the world as resurrected dire wolves – a...
